In the animal models of hypertension, synthesis of EETs was inhibited (Capdevila et al., 2007), and EET levels were upregulated by sEH inhibitors or overexpression of CYP genes, which in turn decreased blood pressure in vivo (Imig et al., 2002; Lee et al., 2010). Here, EPHX2 is linked to hypertensive disorder.